Correlates and Consequences of Increased Immune Activation in Injection Drug Users

Effects of Systemically Administered Hydrocortisone on the Immune System in Healthy Volunteers

NCT01281995 ·Status: COMPLETED

SYSTEMATIC SYMPTOM ASSESSMENT IN CANCER PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS

NCT04929353 ·Status: UNKNOWN ·Phase: NA

Studies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune System

NCT00001158 ·Status: COMPLETED

Understanding Adaptive Immune Response After COVID-19 Vaccination Boosters to Improve Vaccination Strategies in Vulnerable Groups.

NCT06300853 ·Status: RECRUITING ·Phase: NA

Vaccine-induced Immunity in Immunocompromised Patients

NCT06612515 ·Status: RECRUITING

Carcinoembryonic Antigen-loaded Dendritic Cells in Advanced Colorectal Cancer Patients

NCT00228189 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Autologous Antigen-activated Dendritic Cells in the Treatment of Patients With Colorectal Cancer

NCT03214939 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

Dendritic Cell Vaccination in Patients With Lynch Syndrome or Colorectal Cancer With MSI

NCT01885702 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Immunotherapy in Treating Patients With Resected Liver Metastases From Colon Cancer

NCT00003433 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Immuno-Oncology Database and Bioregistry

NCT04656873 ·Status: ACTIVE_NOT_RECRUITING

Study With Dendritic Cell Immunotherapy in Resected Hepatic Metastasis of Colorectal Carcinoma

NCT01348256 ·Status: UNKNOWN ·Phase: PHASE2

A Prospective Study to Observe Adverse Effects in Patients Receiving Anti-PD1 Immunotherapy

NCT05669638 ·Status: RECRUITING

Safety and Effectiveness of a Vaccine for Prostate Cancer That Uses Each Patients' Own Immune Cells.

NCT00289341 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Immune Profiling for Cancer Immunotherapy Response

NCT06116032 ·Status: RECRUITING

Safety and Efficacy Study of Regulatory T Cells in Treating Autoimmune Hepatitis

NCT02704338 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Vaccine Response With NT-I7

NCT04054752 ·Status: WITHDRAWN ·Phase: PHASE1

Improving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had Chemotherapy

NCT01339000 ·Status: TERMINATED ·Phase: PHASE2

Single Center Study Of N-803 Stimulation On Expansion, Enrichment, Proliferation Of Natural Killer Cells Collected By Apheresis

NCT06040918 ·Status: COMPLETED ·Phase: PHASE1

Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer

NCT00823524 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Immune Related-adverse Events in Patients Receiving Immune Checkpoint Inhibitors

NCT04268368 ·Status: UNKNOWN

The Biodistribution of 1-L-(2 Deoxy-2,- 18 Fluoroarabinofuranosyl) Cytosine ([18F]L-FAC) in Healthy Subjects and Patients With Cancer, Autoimmune and Inflammatory Diseases

NCT01180868 ·Status: COMPLETED

Active Immunotherapy Of Metastatic Renal Cell Carcinoma Using Autologous Dendritic Cells Transfected With Autologous Total Tumor RNA

NCT00006431 ·Status: UNKNOWN ·Phase: PHASE1

Safety of Labeled Dendritic Cell (DC) Vaccines and Feasibility of Tracking by Magnetic Resonance Imaging (MRI)

NCT01671592 ·Status: COMPLETED ·Phase: PHASE1

VRC 900: Evaluation of Tissue-Specific Immune Responses in Adults 18 Years of Age and Older

NCT01132859 ·Status: RECRUITING

Immune Adverse Events Registry in Onco-Hematologic Patients Treated With Immunotherapy

NCT07198958 ·Status: NOT_YET_RECRUITING